FDA.reportPublic FDA data

Application 202803

Type
ANDA
Sponsor
SUN PHARM

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001SUMATRIPTAN AND NAPROXEN SODIUMNAPROXEN SODIUM; SUMATRIPTAN SUCCINATETABLET;ORAL500MG;EQ 85MG BASENoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
16714-891Sumatriptan and Naproxen SodiumSumatriptan and Naproxen SodiumNorthStar RxLLCANDACurrent
16714-891Sumatriptan and Naproxen SodiumSumatriptan and Naproxen SodiumNorthStar RxLLCANDACurrent
16714-891Sumatriptan and Naproxen SodiumSumatriptan and Naproxen SodiumNorthStar RxLLCANDACurrent
16714-891Sumatriptan and Naproxen SodiumSumatriptan and Naproxen SodiumNorthStar RxLLCANDACurrent
47335-410Sumatriptan and Naproxen SodiumSumatriptan and Naproxen SodiumSun Pharmaceutical Industries, Inc.ANDACurrent
47335-410Sumatriptan and Naproxen SodiumSumatriptan and Naproxen SodiumSun Pharmaceutical Industries, Inc.ANDACurrent
47335-410Sumatriptan and Naproxen SodiumSumatriptan and Naproxen SodiumSun Pharmaceutical Industries, Inc.ANDACurrent
47335-410Sumatriptan and Naproxen SodiumSumatriptan and Naproxen SodiumSun Pharmaceutical Industries, Inc.ANDACurrent
71800-901Sumatriptan and Naproxen SodiumSumatriptan and Naproxen SodiumInnovida Phamaceutique CorporationANDACurrent